{"id":505571,"date":"2021-06-22T11:07:33","date_gmt":"2021-06-22T15:07:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/"},"modified":"2021-06-22T11:07:33","modified_gmt":"2021-06-22T15:07:33","slug":"phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/","title":{"rendered":"Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n MARLBOROUGH, Mass.<\/span>, June 22, 2021<\/span> \/PRNewswire\/ —\u00a0Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL\u2122) therapeutic platform, today announced that it has rescheduled the Company’s fireside chat being hosted by H.C. Wainwright, which was previously scheduled for today, to July 12, 2021<\/span> at 11 a.m. Eastern Time<\/span>. Details regarding the rescheduled fireside chat will be forthcoming.<\/p>\n

Logo – https:\/\/mma.prnewswire.com\/media\/786567\/Phio_Pharmaceuticals_Logo.jpg<\/a><\/p>\n

\n About Phio Pharmaceuticals Corp.<\/b>\n <\/p>\n

Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL\u2122) therapeutic platform. The Company’s efforts are focused on silencing tumor-induced suppression of the immune system through its proprietary INTASYL platform with utility in immune cells and the tumor micro-environment. Our goal is to develop powerful INTASYL therapeutic compounds that can weaponize immune effector cells to overcome tumor immune escape, thereby providing patients a powerful new treatment option that goes beyond current treatment modalities. For additional information, visit the Company’s website, www.phiopharma.com<\/a>.\u00a0 <\/p>\n

\n Forward Looking Statements<\/b>\n <\/p>\n

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. These statements are based only on our current beliefs, expectations and assumptions regarding the impact to our business and operations by the coronavirus pandemic, results from our preclinical and clinical activities, the development of our product candidates, the ability to obtain future financing, the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements as a result of a number of important factors, including, but not limited to, market and other conditions and those identified in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q under the caption “Risk Factors” and in other filings the Company periodically makes with the SEC. Readers are urged to review these risk factors and to not act in reliance on any forward-looking statements, as actual results may differ from those contemplated by our forward-looking statements. Phio does not undertake to update forward-looking statements to reflect a change in its views, events or circumstances that occur after the date of this release, except as required by law.<\/p>\n

\n Contact Phio Pharmaceuticals Corp.
<\/b>
\n ir@phiopharma.com<\/a>\n <\/p>\n

\n Investor Contact
<\/b>
\n Ashley R. Robinson<\/span>
\n
LifeSci Advisors
arr@lifesciadvisors.com<\/a><\/p>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-hc-wainwright-for-july-12th-301317491.html<\/a><\/p>\n

SOURCE Phio Pharmaceuticals Corp.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire MARLBOROUGH, Mass., June 22, 2021 \/PRNewswire\/ —\u00a0Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL\u2122) therapeutic platform, today announced that it has rescheduled the Company’s fireside chat being hosted by H.C. Wainwright, which was previously scheduled for today, to July 12, 2021 at 11 a.m. Eastern Time. Details regarding the rescheduled fireside chat will be forthcoming. Logo – https:\/\/mma.prnewswire.com\/media\/786567\/Phio_Pharmaceuticals_Logo.jpg About Phio Pharmaceuticals Corp. Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL\u2122) therapeutic platform. The Company’s efforts are focused on silencing tumor-induced suppression of the immune system through its proprietary INTASYL platform … <\/p>\n

Continue reading “Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-505571","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPhio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire MARLBOROUGH, Mass., June 22, 2021 \/PRNewswire\/ —\u00a0Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL\u2122) therapeutic platform, today announced that it has rescheduled the Company’s fireside chat being hosted by H.C. Wainwright, which was previously scheduled for today, to July 12, 2021 at 11 a.m. Eastern Time. Details regarding the rescheduled fireside chat will be forthcoming. Logo – https:\/\/mma.prnewswire.com\/media\/786567\/Phio_Pharmaceuticals_Logo.jpg About Phio Pharmaceuticals Corp. Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL\u2122) therapeutic platform. The Company’s efforts are focused on silencing tumor-induced suppression of the immune system through its proprietary INTASYL platform … Continue reading "Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-22T15:07:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE19311&sd=2021-06-22\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th\",\"datePublished\":\"2021-06-22T15:07:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/\"},\"wordCount\":475,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE19311&sd=2021-06-22\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/\",\"name\":\"Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE19311&sd=2021-06-22\",\"datePublished\":\"2021-06-22T15:07:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE19311&sd=2021-06-22\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NE19311&sd=2021-06-22\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/","og_locale":"en_US","og_type":"article","og_title":"Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th - Market Newsdesk","og_description":"PR Newswire MARLBOROUGH, Mass., June 22, 2021 \/PRNewswire\/ —\u00a0Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL\u2122) therapeutic platform, today announced that it has rescheduled the Company’s fireside chat being hosted by H.C. Wainwright, which was previously scheduled for today, to July 12, 2021 at 11 a.m. Eastern Time. Details regarding the rescheduled fireside chat will be forthcoming. Logo – https:\/\/mma.prnewswire.com\/media\/786567\/Phio_Pharmaceuticals_Logo.jpg About Phio Pharmaceuticals Corp. Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL\u2122) therapeutic platform. The Company’s efforts are focused on silencing tumor-induced suppression of the immune system through its proprietary INTASYL platform … Continue reading \"Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-22T15:07:33+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE19311&sd=2021-06-22","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th","datePublished":"2021-06-22T15:07:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/"},"wordCount":475,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE19311&sd=2021-06-22","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/","name":"Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE19311&sd=2021-06-22","datePublished":"2021-06-22T15:07:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE19311&sd=2021-06-22","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE19311&sd=2021-06-22"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phio-pharmaceuticals-reschedules-fireside-chat-hosted-by-h-c-wainwright-for-july-12th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Phio Pharmaceuticals Reschedules Fireside Chat Hosted by H.C. Wainwright for July 12th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/505571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=505571"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/505571\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=505571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=505571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=505571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}